Joshua Ray

Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report

Allan Wailoo, Mónica Hernández Alava, Andrea Manca et al. · Value in Health · 2017 · 210 citations · Full text

Pharmacy, Health Policy, Health Assessment +16

Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations

Todd Gilmer, Stéphane Roze, William J. Valentine et al. · Health Services Research · 2007 · 82 citations · Full text

Pharmacy, Insurance, Pharmacoeconomics +17

MALE ANTIFERTILITY COMPOUNDS: EFFICACY OF U-5897 IN PRIMATES ( <i>MACACAMULATTA</i> )

K.T. Kirton, Ronald J. Ericsson, Joshua Ray et al. · Reproduction · 1970 · 81 citations

Life Sciences, Animal Sciences, Toxicology +15

Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes

Joshua Ray, Kristina S. Boye, Nicole Yurgin et al. · Current Medical Research and Opinion · 2007 · 56 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Counting the costs of overweight and obesity: modeling clinical and cost outcomes

Daniel M. Tucker, Andrew Palmer, William J. Valentine et al. · Current Medical Research and Opinion · 2006 · 46 citations · Full text

Pharmacy, Geriatric Medicine, Cost-effectiveness Analysis +16